Privi Speciality Chemicals Ltd (NSE:PRIVISCL)
₹ 2,432 +6.6 (+0.27%) Market Cap: 94.98 Bil Enterprise Value: 105.98 Bil PE Ratio: 50.72 PB Ratio: 8.60 GF Score: 71/100

Q4 2025 Privi Speciality Chemicals Ltd Earnings Call Transcript

May 06, 2025 / 11:00AM GMT
Release Date Price: ₹1879.4 (-6.99%)

Key Points

Positve
  • Privi Speciality Chemicals Ltd (BOM:530117) reported its best-ever quarterly and annual financial performance, marking a significant milestone.
  • The company achieved a 28% year-on-year growth in total income for Q4 FY25, reaching INR628 crores.
  • EBITDA for the quarter grew by 50% year-on-year to INR147 crores, with a record high EBITDA margin of 23.5%.
  • The company has developed two new premium products to be launched in the current financial year, indicating ongoing innovation.
  • Privi Speciality Chemicals Ltd (BOM:530117) has a strong export market, contributing 72.5% of total income for the quarter, showcasing its global reach.
Negative
  • The company anticipates it will take another year for its newly commissioned plant to break even, indicating a delay in profitability.
  • There is a limited presence in the US market, which could be a potential risk given global market dynamics.
  • The company refrained from publishing certain sensitive information like quantitative and segment-wise sales, which may concern some investors.
  • Despite strong growth, the company faces challenges in maintaining its high EBITDA margins due to potential market fluctuations.
  • The company has significant debt, with gross debt standing around INR1,100 crores, which could impact future financial flexibility.
Operator

Ladies and gentlemen, good day and welcome to Privi Specialty Chemicals Limited Q4 FY25 earnings conference call. (Operator Instructions) Please note that this conference has been recorded.

This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the companies as on the date of this call. These statements are not the guarantee of future performance and involve risks and uncertainties that are difficult to predict.

I now hand the conference over to Mr. Shrikant Sangani. Thank you, and over to you, sir.

Shrikant Sangani
Strategic Growth Advisors - Investor Relations

Thank you. This is Srikanth Sanghani from SGA. Thank you, everyone, for joining us today to discuss Privi Speciality Chemicals' Q4 and FY25 Business and Financial Performance. The financial results and investor presentation are available on the company's website. The recording of today's earnings call and transcript will be uploaded on the company's website under IR section.

For today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot